COMMUNIQUÉS West-GlobeNewswire

-
Dentsply Sirona to Host Conference Call Regarding Update on Byte Aligner Products
25/10/2024 -
ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.06%
25/10/2024 -
International Institute of Infant Sleep is Shaping the Future of Sleep Consulting with Global Education and Affordable Training
25/10/2024 -
Zymeworks Presents New Preclinical Data on Antibody-Drug Conjugate Programs at EORTC-NCI-AACR Conference
25/10/2024 -
RadNet, Inc. Announces Date of its Third Quarter 2024 Financial Results Conference Call
25/10/2024 -
Revolution Medicines Presents Initial Data from RMC-9805 Monotherapy Study in Patients with Advanced Pancreatic Ductal Adenocarcinoma
25/10/2024 -
Press Release: Sanofi Q3: 15.7% sales growth boosted by earlier-than-anticipated vaccine sales; 2024 business EPS guidance raised due to strong business performance
25/10/2024 -
Communiqué de presse : T3 2024 : Croissance des ventes de 15,7% soutenue par une séquence des ventes de vaccins plus favorable qu’anticipée; Sanofi relève ses perspectives de BNPA des activités 2024 suite à la forte performance
25/10/2024 -
Advanced Care Group Makes a Strong Entrance at Global Health Exhibition, Ready to Lead at Arab Health 2025
25/10/2024 -
Septerna Prices Upsized Initial Public Offering
25/10/2024 -
Vision Sensing Acquisition Corp. Announces Securities Suspension Date and Redemption Amount
24/10/2024 -
Lifeward Ltd. to Present at ThinkEquity Conference on Oct 30, 2024
24/10/2024 -
BioVie Inc. Announces Closing of Registered Direct Offering and Concurrent Private Placement
24/10/2024 -
The Ensign Group Reports Third Quarter 2024 Results; Raises Annual Earnings and Revenue Guidance
24/10/2024 -
Codexis Announces Three siRNA Manufacturing Data Presentations at TIDES Europe Annual Meeting
24/10/2024 -
RxSight, Inc. to Report Third Quarter Financial Results on November 7, 2024
24/10/2024 -
IRADIMED CORPORATION to Hold 2024 Third Quarter Financial Results Conference Call on October 31st
24/10/2024 -
TELA Bio Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
24/10/2024 -
ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2025
24/10/2024
Pages